TY - JOUR
T1 - DDInter: An online drug-drug interaction database towards improving clinical decision-making and patient safety
AU - Xiong, Guoli
AU - Yang, Zhijiang
AU - Yi, Jiacai
AU - Wang, Ningning
AU - Wang, Lei
AU - Zhu, Huimin
AU - Wu, Chengkun
AU - Lu, Aiping
AU - Chen, Xiang
AU - Liu, Shao
AU - Hou, Tingjun
AU - Cao, Dongsheng
N1 - Funding Information:
National Science Foundation of China [2217030451, 21575128, 81773632];ChangshaMunicipalNatural Science Foundation [kq2014144]; Changsha Science and Technology Bureau project [kq2001034]; Zhejiang Provincial Natural Science Foundation of China [LZ19H300001]; Key R&D Program of Zhejiang Province [2020C03010]; Leading Talent of Ten Thousand Plan-National High-Level Talents Special Support Plan; HKBU Strategic Development Fund project [SDF19-0402-P02]; Key Research Project of Ningxia Hui Autonomous Region in 2021 (Major Project) [2021BEG01001]. Funding for open access charge: HKBU Strategic Development Fund project [SDF19-0402-P02].
Publisher Copyright:
© 2022 Oxford University Press. All rights reserved.
© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.
PY - 2022/1/7
Y1 - 2022/1/7
N2 - Drug-drug interaction (DDI) can trigger many adverse effects in patients and has emerged as a threat to medicine and public health. Despite the continuous information accumulation of clinically significant DDIs, there are few open-access knowledge systems dedicated to the curation of DDI associations. To facilitate the clinicians to screen for dangerous drug combinations and improve health systems, we present DDInter, a curated DDI database with comprehensive data, practical medication guidance, intuitive function interface, and powerful visualization to the scientific community. Currently, DDInter contains about 0.24M DDI associations connecting 1833 approved drugs (1972 entities). Each drug is annotated with basic chemical and pharmacological information and its interaction network. For DDI associations, abundant and professional annotations are provided, including severity, mechanism description, strategies for managing potential side effects, alternative medications, etc. The drug entities and interaction entities are efficiently cross-linked. In addition to basic query and browsing, the prescription checking function is developed to facilitate clinicians to decide whether drugs combinations can be used safely. It can also be used for informatics-based DDI investigation and evaluation of other prediction frameworks. We hope that DDInter will prove useful in improving clinical decision-making and patient safety. DDInter is freely available, without registration, at http://ddinter.scbdd.com/.
AB - Drug-drug interaction (DDI) can trigger many adverse effects in patients and has emerged as a threat to medicine and public health. Despite the continuous information accumulation of clinically significant DDIs, there are few open-access knowledge systems dedicated to the curation of DDI associations. To facilitate the clinicians to screen for dangerous drug combinations and improve health systems, we present DDInter, a curated DDI database with comprehensive data, practical medication guidance, intuitive function interface, and powerful visualization to the scientific community. Currently, DDInter contains about 0.24M DDI associations connecting 1833 approved drugs (1972 entities). Each drug is annotated with basic chemical and pharmacological information and its interaction network. For DDI associations, abundant and professional annotations are provided, including severity, mechanism description, strategies for managing potential side effects, alternative medications, etc. The drug entities and interaction entities are efficiently cross-linked. In addition to basic query and browsing, the prescription checking function is developed to facilitate clinicians to decide whether drugs combinations can be used safely. It can also be used for informatics-based DDI investigation and evaluation of other prediction frameworks. We hope that DDInter will prove useful in improving clinical decision-making and patient safety. DDInter is freely available, without registration, at http://ddinter.scbdd.com/.
KW - Clinical Decision-Making
KW - Databases, Factual
KW - Drug Interactions/genetics
KW - Drug-Related Side Effects and Adverse Reactions/classification
KW - Humans
KW - Patient Safety
KW - Software
UR - http://www.scopus.com/inward/record.url?scp=85125289255&partnerID=8YFLogxK
U2 - 10.1093/nar/gkab880
DO - 10.1093/nar/gkab880
M3 - Journal article
C2 - 34634800
AN - SCOPUS:85125289255
SN - 0305-1048
VL - 50
SP - D1200-D1207
JO - Nucleic Acids Research
JF - Nucleic Acids Research
IS - D1
ER -